Recombinant, adjuvanted vaccine designed to help protect adults against shingles.
Prevention of herpes zoster (shingles) and post-herpetic neuralgia in eligible adults.
Attributes
Medical Attributes
-
Active Ingredient:
Recombinant varicella-zoster virus glycoprotein E
AS01B adjuvant
Product Content
-
How to Use:
2 intramuscular doses; usually 2–6 months apart, with shorter interval possible in certain circumstances.